Alphaxalone infusion during cardiopulmonary bypass

Area of Science:

• Anesthesiology
• Pharmacology
• Cardiovascular Surgery

Background:

• Maintaining anesthesia during complex cardiac procedures is critical.
• Alphaxalone (Althesin) is an anesthetic agent requiring pharmacokinetic evaluation in specific surgical contexts.

Purpose of the Study:

• To assess the efficacy and pharmacokinetics of continuous alphaxalone infusion for open-heart surgery.
• To determine if alphaxalone provides adequate anesthesia despite cardiopulmonary bypass and hypothermia.

Main Methods:

• Continuous infusion of alphaxalone (Althesin) was administered to patients.
• Plasma drug levels were monitored throughout open-heart surgery.
• Anesthetic suitability was evaluated during the procedure.

Main Results:

• Alphaxalone provided suitable anesthesia for open-heart surgery.
• Adequate removal of alphaxalone from circulation was observed.
• Drug clearance was effective even with cardiopulmonary bypass and hypothermia.

Conclusions:

• Continuous alphaxalone infusion is a viable anesthetic option for open-heart surgery.
• The drug's pharmacokinetic profile supports its use in cardiac procedures involving bypass and hypothermia.